American College of Cardiology
Avatar

TCT 2022: PCSK9 Inhibition, FAVOR III China, and SCAAR Studies

By American College of Cardiology FEATURING Deepak Bhatt, Roxana Mehran, Bina Ahmed
By American College of Cardiology FEATURING Deepak Bhatt, Roxana Mehran, Bina Ahmed
14 views
September 20, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
07:30
Boston Scientific

The Use of Drug Coated Balloons in Modern PCI

Feat. S. Walsh
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

11:49
Cipriano Abad

OFF-PUMP CORONARY ARTERY BYPASS GRAFT: LIMA-DA

18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
21:34
Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
09:42
HeartFlow

Can obese patients benefit from the Coronary CTA pathway to diagnose…

Feat. M. Ferencik
11:08
Kristian Tækker Madsen

Prognostic Value of FFR-CT - Results from ADVANCE-DK Trial

19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
21:48
Canadian Collaborative Research Network

I Ordered an Lp(a) Level – Now What?

Feat. M. O'Donoghue
45:50
Joel Gorfinkel

The History of Invasive Cardiac Procedures - Updated

33:43
Jefferson Health

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Feat. A. Cohen